| Abstract [eng] |
This Master Thesis deals with the topic: Social Capital Development in Boehringer Ingelheim RCV GmbH & Co KG. Actuality of the topic is reflected by the fact that constantly changing technologies, accelerating the globalization of markets and increasing competition among companies, encourage companies to look for new opportunities for business development and growth. The global and local economic market is constantly changing, so companies, organizations and other social groups seeking business development and growth must strive to maintain mutually beneficial relationships both internally and externally. More and more information on the impact of social capital in the context of company development is being presented. There has been a lot of research on social capital, but it is not enough to set out specific social capital formation and development in the company. In the scientific literature, aspects of social capital formation and development can be found in voluntary organizations, state institutions, various communities, e.g. where the individual shares his or her social capital voluntarily, no one is encouraged artificially, but information on how to form and develop social capital in companies is not enough. This paper explores opportunities for social capital development at Boehringer Ingelheim, a pharmaceutical company. The work raises a problem that emphasizes the relevance of the work: how and which tools are required to boost social capital formation for business development and growth. The aim of the thesis is to reveal the possibilities of social capital development in the pharmaceutical company Boehringer Ingelheim RCV GmbH & Co. KG. The task is to analyze theoretical and practical assumptions for the company's social capital development; to create and develop a methodology for the study (questionnaire) of social capital development opportunities; to carry out an empirical study and offer social capital development opportunities at the current pharmaceutical company. It is believed that social capital is formed in the internal and external environment of the company, so it is very important to analyze this environment. An empirical study was used to analyze the social capital development opportunities of the pharmaceutical company Boehringer Ingelheim, which identified the factors that determine the development of social capital in this company and assessed the possibilities of implementing social capital development solutions. There are also recommendations for social capital development opportunities at this particular pharmaceutical company. |
